ICON Public Limited Company (ICLR)
USD 142.96
(-1.55%)
USD 142.96
(-1.55%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8.12 Billion USD | 4.89% |
| 2022 | 7.74 Billion USD | 41.24% |
| 2021 | 5.48 Billion USD | 95.93% |
| 2020 | 2.79 Billion USD | -0.3% |
| 2019 | 2.8 Billion USD | 8.09% |
| 2018 | 2.59 Billion USD | 47.62% |
| 2017 | 1.75 Billion USD | 5.52% |
| 2016 | 1.66 Billion USD | 5.81% |
| 2015 | 1.57 Billion USD | 4.77% |
| 2014 | 1.5 Billion USD | 12.52% |
| 2013 | 1.33 Billion USD | 19.83% |
| 2012 | 1.11 Billion USD | 17.9% |
| 2011 | 945.72 Million USD | 5.08% |
| 2010 | 900.04 Million USD | 1.4% |
| 2009 | 887.61 Million USD | 2.58% |
| 2008 | 865.24 Million USD | 37.18% |
| 2007 | 630.72 Million USD | 38.44% |
| 2006 | 455.59 Million USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 296.92 Million USD | 31.54% |
| 2003 | 225.72 Million USD | 44.18% |
| 2002 | 156.55 Million USD | 34.77% |
| 2001 | 116.16 Million USD | 43.82% |
| 2000 | 80.76 Million USD | 44.74% |
| 1999 | 55.8 Million USD | 32.54% |
| 1998 | 42.1 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 2.03 Billion USD | -4.25% |
| 2024 Q2 | 2.12 Billion USD | 1.42% |
| 2024 Q1 | 2.09 Billion USD | 1.17% |
| 2023 Q1 | 1.97 Billion USD | 0.84% |
| 2023 FY | 8.12 Billion USD | 4.89% |
| 2023 Q4 | 2.06 Billion USD | 0.54% |
| 2023 Q2 | 2.02 Billion USD | 2.11% |
| 2023 Q3 | 2.05 Billion USD | 1.72% |
| 2022 FY | 7.74 Billion USD | 41.24% |
| 2022 Q1 | 1.9 Billion USD | 0.88% |
| 2022 Q2 | 1.93 Billion USD | 1.76% |
| 2022 Q3 | 1.94 Billion USD | 0.37% |
| 2022 Q4 | 1.96 Billion USD | 1.01% |
| 2021 FY | 5.48 Billion USD | 95.93% |
| 2021 Q1 | 858.19 Million USD | 12.89% |
| 2021 Q4 | 1.88 Billion USD | 1.01% |
| 2021 Q3 | 1.86 Billion USD | 114.24% |
| 2021 Q2 | 871.15 Million USD | 1.51% |
| 2020 Q4 | 760.22 Million USD | 8.34% |
| 2020 Q3 | 701.72 Million USD | 13.14% |
| 2020 FY | 2.79 Billion USD | -0.3% |
| 2020 Q2 | 620.22 Million USD | -13.27% |
| 2020 Q1 | 715.1 Million USD | -1.42% |
| 2019 Q2 | 695.13 Million USD | 3.01% |
| 2019 Q1 | 674.85 Million USD | -0.61% |
| 2019 Q3 | 710.44 Million USD | 2.2% |
| 2019 FY | 2.8 Billion USD | 8.09% |
| 2019 Q4 | 725.4 Million USD | 2.11% |
| 2018 Q2 | 641.61 Million USD | 3.46% |
| 2018 FY | 2.59 Billion USD | 47.62% |
| 2018 Q3 | 655.01 Million USD | 2.09% |
| 2018 Q4 | 679.02 Million USD | 3.67% |
| 2018 Q1 | 620.12 Million USD | 36.25% |
| 2017 Q3 | 440.32 Million USD | 2.16% |
| 2017 Q2 | 431.02 Million USD | -0.22% |
| 2017 Q1 | 431.95 Million USD | -0.73% |
| 2017 FY | 1.75 Billion USD | 5.52% |
| 2017 Q4 | 455.13 Million USD | 3.36% |
| 2016 Q4 | 435.13 Million USD | 3.55% |
| 2016 Q3 | 420.2 Million USD | 2.33% |
| 2016 Q1 | 400.52 Million USD | -0.7% |
| 2016 FY | 1.66 Billion USD | 5.81% |
| 2016 Q2 | 410.63 Million USD | 2.52% |
| 2015 Q1 | 388.23 Million USD | -0.47% |
| 2015 Q3 | 394.74 Million USD | 1.57% |
| 2015 FY | 1.57 Billion USD | 4.77% |
| 2015 Q4 | 403.34 Million USD | 2.18% |
| 2015 Q2 | 388.65 Million USD | 0.11% |
| 2014 Q1 | 349.63 Million USD | 1.27% |
| 2014 FY | 1.5 Billion USD | 12.52% |
| 2014 Q4 | 390.07 Million USD | 0.64% |
| 2014 Q2 | 376.02 Million USD | 7.55% |
| 2014 Q3 | 387.58 Million USD | 3.08% |
| 2013 Q4 | 345.24 Million USD | 1.6% |
| 2013 Q3 | 339.81 Million USD | 1.67% |
| 2013 Q2 | 334.21 Million USD | 5.5% |
| 2013 FY | 1.33 Billion USD | 19.83% |
| 2013 Q1 | 316.78 Million USD | 5.54% |
| 2012 Q1 | 252.33 Million USD | 4.01% |
| 2012 Q2 | 277 Million USD | 9.78% |
| 2012 Q3 | 285.5 Million USD | 3.07% |
| 2012 Q4 | 300.16 Million USD | 5.14% |
| 2012 FY | 1.11 Billion USD | 17.9% |
| 2011 Q2 | 233.04 Million USD | 1.63% |
| 2011 Q4 | 242.61 Million USD | 0.77% |
| 2011 Q3 | 240.77 Million USD | 3.32% |
| 2011 FY | 945.72 Million USD | 5.08% |
| 2011 Q1 | 229.29 Million USD | -1.2% |
| 2010 Q3 | 225.09 Million USD | 0.6% |
| 2010 Q2 | 223.75 Million USD | 2.12% |
| 2010 Q1 | 219.11 Million USD | -3.65% |
| 2010 FY | 900.04 Million USD | 1.4% |
| 2010 Q4 | 232.08 Million USD | 3.11% |
| 2009 Q4 | 227.41 Million USD | 3.2% |
| 2009 Q1 | 219.83 Million USD | -0.12% |
| 2009 FY | 887.61 Million USD | 2.58% |
| 2009 Q3 | 220.36 Million USD | 0.16% |
| 2009 Q2 | 220 Million USD | 0.08% |
| 2008 Q1 | 201.34 Million USD | 11.44% |
| 2008 FY | 865.24 Million USD | 37.18% |
| 2008 Q4 | 220.09 Million USD | -2.4% |
| 2008 Q3 | 225.51 Million USD | 3.3% |
| 2008 Q2 | 218.3 Million USD | 8.42% |
| 2007 Q3 | 166.91 Million USD | 13.51% |
| 2007 FY | 630.72 Million USD | 38.44% |
| 2007 Q1 | 136.08 Million USD | 5.53% |
| 2007 Q4 | 180.67 Million USD | 8.24% |
| 2007 Q2 | 147.04 Million USD | 8.05% |
| 2006 FY | 455.59 Million USD | 0.0% |
| 2006 Q3 | 120.71 Million USD | 12.36% |
| 2006 Q4 | 128.95 Million USD | 6.82% |
| 2006 Q1 | 98.49 Million USD | 11.83% |
| 2006 Q2 | 107.43 Million USD | 9.08% |
| 2005 Q4 | 88.07 Million USD | 2.5% |
| 2005 FY | - USD | -100.0% |
| 2005 Q1 | 82.85 Million USD | 4.23% |
| 2005 Q2 | 85.96 Million USD | 3.76% |
| 2005 Q3 | 85.92 Million USD | -0.06% |
| 2004 FY | 296.92 Million USD | 31.54% |
| 2004 Q2 | 77.91 Million USD | 1.38% |
| 2004 Q3 | 78.33 Million USD | 0.54% |
| 2004 Q4 | 79.49 Million USD | 1.48% |
| 2004 Q1 | 76.86 Million USD | 4.99% |
| 2003 Q1 | 59.31 Million USD | 10.79% |
| 2003 FY | 225.72 Million USD | 44.18% |
| 2003 Q4 | 73.2 Million USD | 6.2% |
| 2003 Q3 | 68.93 Million USD | 4.42% |
| 2003 Q2 | 66.02 Million USD | 11.31% |
| 2002 Q4 | 53.53 Million USD | 14.25% |
| 2002 FY | 156.55 Million USD | 34.77% |
| 2002 Q2 | 42.99 Million USD | 8.66% |
| 2002 Q1 | 39.57 Million USD | 4.77% |
| 2002 Q3 | 46.85 Million USD | 8.98% |
| 2001 Q3 | 36.21 Million USD | 14.82% |
| 2001 Q1 | 29.73 Million USD | 4.05% |
| 2001 Q4 | 37.76 Million USD | 4.28% |
| 2001 Q2 | 31.54 Million USD | 6.09% |
| 2001 FY | 116.16 Million USD | 43.82% |
| 2000 Q3 | 26.3 Million USD | 17.45% |
| 2000 Q4 | 28.57 Million USD | 8.63% |
| 2000 Q2 | 22.39 Million USD | 8.04% |
| 2000 Q1 | 20.73 Million USD | 15.82% |
| 2000 FY | 80.76 Million USD | 44.74% |
| 1999 Q4 | 17.9 Million USD | 5.29% |
| 1999 FY | 55.8 Million USD | 32.54% |
| 1999 Q2 | 14.5 Million USD | -1.36% |
| 1999 Q1 | 14.7 Million USD | 7.3% |
| 1999 Q3 | 17 Million USD | 17.24% |
| 1998 Q4 | 13.7 Million USD | 7.03% |
| 1998 Q2 | 12.1 Million USD | 21.0% |
| 1998 Q1 | 10 Million USD | 0.0% |
| 1998 FY | 42.1 Million USD | 0.0% |
| 1998 Q3 | 12.8 Million USD | 5.79% |
| 1997 Q4 | 10 Million USD | 0.0% |
| 1997 Q3 | 10 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 31.24 Million USD | -25885.395% |
| Biodesix, Inc. | 49.08 Million USD | -16442.417% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -320538.863% |
| Castle Biosciences, Inc. | 219.78 Million USD | -3594.549% |
| DarioHealth Corp. | 20.35 Million USD | -39798.664% |
| Exact Sciences Corporation | 2.49 Billion USD | -224.837% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -121.805% |
| Illumina, Inc. | 4.5 Billion USD | -80.288% |
| Intelligent Bio Solutions Inc. | 3.11 Million USD | -260849.469% |
| iSpecimen Inc. | 9.92 Million USD | -81689.137% |
| Standard BioTools Inc. | 106.34 Million USD | -7536.05% |
| 23andMe Holding Co. | 219.63 Million USD | -3597.072% |
| Medpace Holdings, Inc. | 1.88 Billion USD | -330.586% |
| NeoGenomics, Inc. | 591.64 Million USD | -1272.479% |
| Inotiv, Inc. | 572.42 Million USD | -1318.557% |
| Psychemedics Corporation | 22.09 Million USD | -36646.203% |
| Prenetics Global Limited | 21.74 Million USD | -37246.72% |
| Precipio, Inc. | 15.19 Million USD | -53332.756% |
| RadNet, Inc. | 1.61 Billion USD | -402.29% |
| Sotera Health Company | 1.04 Billion USD | -673.875% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -17635.45% |
| Exagen Inc. | 52.54 Million USD | -15352.874% |
| Natera, Inc. | 1.08 Billion USD | -650.083% |
| Aspira Women's Health Inc. | 9.15 Million USD | -88606.314% |
| Neogen Corporation | 924.22 Million USD | -778.596% |
| Myriad Genetics, Inc. | 678.4 Million USD | -1096.96% |
| Bionano Genomics, Inc. | 36.11 Million USD | -22383.597% |
| CareDx, Inc | 280.32 Million USD | -2796.711% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 312.97 Million USD | -2494.521% |
| Guardant Health, Inc. | 563.94 Million USD | -1339.88% |
| BioNexus Gene Lab Corp. | 9.77 Million USD | -83006.511% |
| Fulgent Genetics, Inc. | 289.21 Million USD | -2707.68% |
| Sera Prognostics, Inc. | 306 Thousand USD | -2653552.288% |
| OPKO Health, Inc. | 863.49 Million USD | -840.385% |
| Personalis, Inc. | 73.48 Million USD | -10950.715% |
| Applied DNA Sciences, Inc. | 13.36 Million USD | -60645.918% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -17635.45% |
| MDxHealth SA | 70.19 Million USD | -11468.356% |
| Prenetics Global Limited | 21.74 Million USD | -37246.72% |
| ENDRA Life Sciences Inc. | - USD | -Infinity% |
| Mainz Biomed B.V. | 895.47 Thousand USD | -906696.921% |
| Trinity Biotech plc | 56.83 Million USD | -14188.035% |
| Neuronetics, Inc. | 71.34 Million USD | -11281.084% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -320538.863% |